Search for: "Abbott Products Inc" Results 601 - 620 of 664
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
10 Jun 2010, 1:54 pm by Bexis
Medtronic, Inc., 552 U.S. 312 (2008):  Lewkut v. [read post]
25 Feb 2010, 10:57 am by admin
The other three defendants include the City of West Point, West Point Dairy Products, LLC, (WPDP); and Wimmers Meat Products, Inc. [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent… [read post]
9 Apr 2015, 11:59 am by Lawrence B. Ebert
The important university patents seem to be in biotechnology areas. n118 Though universities are generally large entities, like NPEs, they have limited exposure because they do not make products. [read post]
20 Aug 2021, 4:00 am by Jim Sedor
Boebert reported her husband, Jayson Boebert, received the money as a consultant to Terra Energy Productions in 2020, and earned $460,000 as a consultant for the firm in 2019. [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from… [read post]
8 Feb 2011, 1:42 pm by Steve Hall
And: The drug was developed by Abbott Laboratories in the 1930s and produced until about 2004, when Abbott spun off a new company called Hospira Inc. [read post]
8 Sep 2022, 5:55 am by Kaya van der Horst
Glock, Inc. (9th Cir. 2009), for example, plaintiffs argued that the gun manufacturers’ marketing practices constituted a public nuisance under California law because such conduct “significantly interferes with the public safety, health or peace. [read post]
2 May 2008, 7:00 am
: (Intellectual Property Watch), Open licensing vs monopoly controlled supply: (KEI), Protecting inventions involving biofuel feedstock: (IP Law360), Brazil: ‘Public interest’ factor in Brazil’s patenting system: (Spicy IP), EU: Regulation (EC) 1394/2007 on advanced medicinal products to enter into force soon, creating certification procedure regarding quality and non-clinical data: (Catch Us If You Can!!!) [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
2 Aug 2010, 11:15 am by Steven M. Taber
Colan Associates of Florida, LLC and The Jones Payne Group, Inc., of Mass., have agreed to pay $25,000 for alleged violations of the federal Clean Air Act and National Emission Standard for Hazardous Air Pollutants for Asbestos. [read post]